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CLINICAL INVESTIGATION
Differentially regulated cell surface expression of leukocyte
adhesion receptors on neutrophils
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Differentially-regulated cell surface expression of leukocyte adhesion
receptors on neutrophils. To elucidate the molecular mechanisms ac-
counting for hemodialysis-induced neutropenia, the regulation of
plasma membrane expression of leukocyte adhesion glycoproteins was
investigated by both flow cytometry and immunoprecipitation tech-
niques. The members of the LFA family of integrins, Mac-l/Mol
(CD! l/CD18) and gpl5O/95 (CDI Ic/CD18), involved in adhesion of
myeloid cells to endothelia and other substrates, were found to be
overexpressed on the plasma membrane of neutrophils from patients
undergoing hemodialysis with a Cuprophane dialyzer, whereas no
change was observed in the expression of LFA-I (CD1 la/CD 18). By
contrast, dialysis with Cuprophane membranes, as well as in vitro
treatment with different activating agents, induced a downregulation on
the expression of both the Leu-8/LAM-1 antigen, the human neutrophil
peripheral lymph node homing receptor, and the CD43 major sialogly-
coprotein involved in leukocyte homotypic adhesion. Kinetics studies
showed that these up- and downregulatory processes of antigen expres-
sion occur very rapidly, correlating with maximal neutropenia. Recov-
ery of initial levels of expression of CD! lb/CD18 and Leu-8/LAM-l
adhesion molecules was observed after one hour of hemodialysis.
However, the basal expression of CD43 was not restored by that time.
The coordinated upregulation of CDI lb and CD! lc and downregulation
of LAM-l and CD43 adhesion receptors provide molecular mechanisms
for understanding leukoaggregation, adherence to endothelia, and ex-
travasation of neutrophils ultimately leading to the hemodialysis-in-
duced neutropenia.
Profound neutropenia occurs in a!l patients during the initial
phases of hemodialysis therapy with cellulosic membranes such
as Cuprophane [!}. In the hemodialysis process, the alternative
pathway of complement is activated by direct contact of plasma
with dialysis membrane, resulting in the generation of active
peptides C3a and C5a which can induce physiologic responses
in neutrophils and monocytes by interaction with specific
receptors [2, 31. Circulating neutrophils, which exhibit negligi-
ble binding affinity for vascular endothelium, acquire the capac-
ity to transiently interact with endothelium after intravenous
administration of a chemotactic factor such as C5a [4—7].
A wide array of receptor-ligand molecular interactions regu-
lates the adherence, extravasation and migration of leukocytes
through endothelial cells during trafficking to different tissues
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[8]. The leukocyte integrin family has been involved in the
adherence of neutrophils to other leukocytes and endothelia,
and in the neutrophil extravasation process, as demonstrated by
both experiments in vitro and by the study of patients with a
genetic deficiency in CD18 expression [9—!2]. These constitute
a family of three heterodimers, formed by a common p subunit
(CD 18) non-covalently associated with distinct a subunits des-
ignated as LFA-! (CD!!a), Mo!/Mac-l (CD11b) and gp!50
(CD! !c) [!3]. The LFA-l member is involved in cell-cell
interactions, thus, being crucial in the adhesive function of all
leukocyte cell types [9, !0]. Mac! and gp!50,95 function as
complement receptors and they are also involved in the adhe-
sion of monocytes and neutrophi!s to endothelia! cells and other
substrates [!4].
The migration of leukocytes to secondary lymphoid organs or
at sites of inflammation constitutes a process which is selec-
tively regulated by the interaction of leukocyte specific recep-
tors to their molecular counterparts on endothe!ial cells [!5, 16].
A new family of cellular adhesion molecules, termed selectins,
has been recently identified by cDNA c!oning, and its genomic
organization found to be located in chromosome 1 [!7, !8].
Among them, the MEL-14 homing receptor has been involved
in the homing process of mouse lymphocytes to peripheral
lymph nodes [!9]. Antibodies specific for MEL-14 prevent
mouse neutrophil migration to subcutaneous inflammatory sites
and inflammed peritoneum, and abrogate the binding of both
lymphocytes and granulocytes to vascular endothelium within
tissue sections of lymph nodes [20]. The human homologue of
MEL-14, the Leu-8/LAM-! (leukocyte adhesion molecule !)
antigen, has been also identified and cloned [21, 22]. Recent!y,
a soluble homing receptor Mel-!4-IgG chimera has been found
to inhibit in vivo neutrophil migration into inflammatory sites
[23]. Other molecules, such as CD44 or VLA-4, have been also
shown to participate in the homing process [24—26].
Human sialophorin (!eukosialin or CD43) is a heavily sialy-
lated protein which has been found on the cell surface of all
leukocytes [27, 28]. This sialoglycoprotein, which is defective
in Wiskott-A!drich syndrome, has been recently reported to
participate in T lymphocyte and monocyte activation as well as
in the triggering of homotypic aggregation of both cell types [29,
30], thus suggesting a role for this molecule in cell adhesive
interactions.
We investigated the regulatory changes in the expression of
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different leukocyte adhesion receptors on neutrophils from
patients undergoing hemodialysis with Cuprophane dialyzers.
Methods
Subjects
Twenty different patients undergoing regular hemodialysis
treatment were studied. Ilemodialysis was performed three
times weekly using dialyzers made from Cuprophane (10 pa-
tients) and polyacrylonitnie (10 patients). Heparinized blood
was drawn from the efferent limb of the dialyzer at the begin-
ning of and during hemodialysis from the patient's arterovenous
fistula. All blood samples were anticoagulated with EDTA.
Samples were analyzed using a Coulter counter for white blood
cell determination. Blood samples were obtained from patients
after informed consent.
Cells
Neutrophils were isolated at room temperature as described
[311. Briefly, after sedimentation of erythrocytes with dextran
and separation of mononuclear cells by centrifugation on Lym-
phoprep (Pharmacia Fine Chemicals, Uppsaia, Sweden), neu-
trophils were purified by hypotonic lysis of erythrocytes, giving
a purity higher than 98%.
Monoclonal antibodies
The (mAb) used in the study were the anti-LFA- 1 alpha
(CD11a) TS1/1l and the mAb anti-LFA beta (CD18) TS1/l8
[13]. Anti-Mol/Mac-l (CDllb) and anti-gpl5O were the mAb
Bear-i and HC1/!, respectively [32]. The mAb HP2/21 and
MC7/1 specific for the CD43 molecule were obtained in our
laboratory and will be described elsewhere. The mAb Leu-8
anti-LAM-i was purchased from Becton-Dickinson (Mountain
View, California, USA). P3X63 myeloma culture supernatant
was used as negative control. The mAb were used as hybridoma
culture supernatants.
Flow cytometry analysis
Cells at 2 x l06/ml (100 d) were incubated with 100 l of
mAb culture supernatant for 30 minutes at 4°C, washed twice
with phosphate-buffered saline and suspended in 100 td fluo-
rescein isothyocianate (FITC) conjugate goat anti-mouse IgG
(Kallestad, Austin, Texas, USA), previously diluted 1:40 in
phosphate buffered saline. Subsequently, cells were washed
three times and subjected to immunofluorescence flow cytom-
etry in an EPICS-C cytofluorometer (Coulter Scientific,
Harpeaden, England, UK). Fluorescence data were collected
both on log and linear scales. Specific linear fluorescence was
obtained by subtracting control fluorescence obtained with
P3X63 mAb.
Radiolabeling, immunoprecipitation and electrophoresis
To perform biochemical analysis of adhesion receptor mole-
cules, purified neutrophils were radioiodinated in solution with
chloroglycoluril (IODO-GEN, Pierce Chemical Co, Rockford,
Illinois, USA). Cells were lysed in PBS pH 7.4 containing 1%
Triton X-lOO, 1% hemoglobin and 1 mi PMSF. For immuno-
precipitation, equal amounts of input radioactivity of 125!
labeled proteins from each cell lysate were mixed with 100 1d of
mAb-containing culture supernatants. To isolate immune com-
plexes 100 d of 187.1 anti-mouse Kappa chain mAb followed
by 30 .d of protein A from S. aureus coupled to Sepharose
(Pharmacia) were added. Immunoprecipitates were processed
as previously described [13], and samples were subjected to
SDS-7% PAGE and autoradiography.
Neutrophil activation
Neutrophils were resuspended at 3 x i0 cells/ml in cold
Hepes/glucose buffer (150 m'vi NaCI, 5 mvi KOH, 10 mM
Hepes, 1.2 mM MgCl2, 1.3 mri CaC12, 5.5 msi glucose, pH 7.5)
and incubated at 37°C with the activating agents for 15 minutes.
Calcium ionophore A23 187 was employed at 3 x 106 M, and
fMLP at i0 M. All agents were from Sigma (St. Louis,
Missouri, USA). Cells held at 4°C or incubated at 37°C in the
absence of any stimulus were run in parallel.
Results
We investigated the expression of the different members of
the family of leukocytes (CDila, CDllb, CDllc and CD18) on
neutrophils from hemodialysis patients before and 15 minutes
after dialysis with Cuprophane membranes, A noticeable in-
crease in the cell surface expression of the alpha subunits of
Moi (CD1 ib) and gp!50 (CD! ic) in addition to that of the
common beta chain (CD18) was observed. However, no signif-
icant change on the expression of LFA-l alpha chain (CD1 la)
was seen (Fig. 1).
The changes in the neutrophil plasma membrane expression
of the homing receptor Leu-8/LAM- 1 and the CD43 sialoglyco-
protein were also studied. As shown in Figure 2, a decrease in
the plasma membrane expression of these two antigens was
observed after 15 minutes of dialysis in Cuprophane mem-
branes. Similar but stronger downregulatory effects on their
expression were induced by in vitro treatment of resting neu-
trophils with different activating agents, such as fMLP and the
Ca2 ionophore A23 187 (Fig. 2).
Quantitative flow cytometry immunofluorescence values of
the neutrophil cell surface expression of these adhesion recep-
tors, obtained from ten different patients under Cuprophane
dialysis treatment, are summarized in Table 1. By contrast, no
change was observed with a different dialyzer, polyacrylonitrile
(Table 1).
The results above described were confirmed by semiquanti-
tative immunoprecipitation analysis of '251-labeled cell lysates
from neutrophils obtained before and after 15 minutes of
dialysis. A strong increase in the intensities of the bands
corresponding to CD! ib, CD1 ic and CD!8 polypeptides was
observed in dialyzed samples as compared to those of predial-
ysis (Fig. 3, compare lanes 2 and 1, respectively). As expected,
no significant change was appreciated in the CD! la polypeptide
precipitated by anti-LFA-! mAb. On the other hand, a decrease
in the intensity of the band corresponding to CD43 was ob-
served in the precipitation from neutrophils obtained after 15
minutes of dialysis (Fig. 3, lane 2) as well as that found after
treatment of neutrophils with the Ca2 ionophore A23 187 (Fig.
3, lane 4).
The regulatory effects on the cell surface expression of these
adhesion related glycoproteins took place very rapidly and were
time dependent. Kinetics studies showed that the maximum
increase on the expression of CD! lb and CD18 was reached
after 15 minutes of dialysis, returning to normal values after 60
Fig. 1. Immunofluorescence flow
cytometry analysis of CD11/CDJ8
plasma membrane expression on
neutrophils from patients undergoing
hemodialysis with Cuprophane.
Neutrophils from predialysis (dashed
line) or after Cuprophane dialysis for 15
mm (solid line) were stained with mAb
specific for CD11a (TS1/l1), CDI1b
(Bear 1), CDllc (HCI/l) and CDI8
(TS1/18). Samples were processed as
described in Methods. This is a
representative experiment showing
cytofluorimetric profiles of one out of
ten hemodialysis patients studied.
Fig. 2. Comparison of the effect on LAM-i and CD43 neutrophil plasma membrane expression of Cuprophane dialysis with the in vitro activation
by degranulatory stimuli. Neutrophils obtained from predialysis (dashed line) and activated (solid line) after Cuprophane dialysis for 15 mm (A),
neutrophils treated in vitro with fMLP (B), or the Ca2 ionophore A23187 (C) were stained with anti-LAM-i Leu8 or anti-CD43 HP2/21 mAb and
then analyzed by immunofluorescence flow cytometry as described in Methods. This is a representative experiment showing cytofluorimetric
profiles of one out of ten hemodialysis patients studied.
minutes (Fig. 4A). The downregulatory effect on the expression
of Leu-8/LAM- 1 followed a similar kinetics profile to that
described above for the upregulation of CD11b. However,
downregulation of CD43 expression occurred as rapidly as that
of Leu-8/LAM- 1, but did not return to initial levels after 60
minutes of hemodialysis (Fig. 4B), suggesting a different mech-
anism of antigen modulation.
The kinetics of the up- and downregulation of these glyco-
proteins after dialysis correlated and paralleled that of the
decrement of the number of neutrophils in blood at different
times after the beginning of dialysis (Fig. 4C). By contrast,
hemodialysis in polyacrylonitrile membranes did not signifi-
cantly affect neutrophil counts (Fig. 4C).
Discussion
In this report, we describe the inverse regulation on the
neutrophil cell surface expression of different adhesion recep-
tors during the process of hemodialysis with Cuprophane dia-
lyzer. We have found a coordinated upregulation in the expres-
sion of the leukocyte CD11b, CDllc, and CD18, and
downregulation in the expression of the homing receptor Leu-
8/LAM-l and the CD43 sialoglycoprotein. These effects on
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Table 1. Changes of plasma membrane antigen expression on neutrophils from patients subjected to hemodialysis with different membranes
mAb
Ag
specificity CD
Before
dialysis
After dialysis
Polyacrylonitrile
(15 mm)
Cuprophane
(15 mm) p
IS1/il
Bear!
TSI/18
Leu8
HP2/21
LFA-l
MOl/Mac-l
/32 chain
LAM-I
gplO5
CD11a
CD11b
CD!!!
—
CD43
23 659 932 742 7
51 20
23 8
139 30
66 30
10 3
20 8
NS
<0.01
<0.05
<0.05
<0.05
22 5
61 12
32 16
46 8
50 10
Values are shown as mean SE of specific linear fluorescence of 10 experiments, performed on neutrophils from 10 different hemodialysis
patients with each dialyzer membrane. Specific linear fluorescence values were obtained by subtracting fluorescence obtained with P3X63 IgGi
myeloma protein as negative control. The non-parametric Wilcoxon's test for paired values before and after dialysis with Cuprophane has been
used. NS = non-significant.
CD18 CD11b CD11c CD11a
I 21 2111 2l[1 21
Fig. 3. Immunoprecipitation analysis of CDII/CDI8 integrins and CD43 sialophorin on predialysis and Cuprophane-dialyzed neutrophils. '251-cell
surface labeled predialysis (lane 1) or Cuprophane-dialyzed 15 mm (lane 2) neutrophils were immunoprecipitated with mAb specific for the distinct
chains of the CD! 1/CD18 family or the CD43 antigen. Precipitates with anti-CD43 MC7/1 mAb from resting or Ca2 ionophore activated
neutrophils were also included (lanes 3 and 4, respectively). Samples were processed as described in Methods. This is one representative
experiment of three independent precipitation analyses performed with different hemodialysis patients.
antigen expression take place very rapidly and parallel the
decline of neutrophil counts in blood. No significant changes on
plasma membrane antigen expression were observed when
hemodialysis was performed with polyacrylonitrile membranes,
which were unable to induce appreciable neutropenia.
Leukoaggregatjon, cell adhesion to endothelia, and pulmonary
sequestration of neutrophils have been proposed to constitute
possible mechanisms accounting for the hemodialysis-induced
neutropenia associated with the first use of Cuprophane dialyzers
[7, 33—35]. Circulating neutrophils, unable to significantly form
leukoaggregates or bind to unstimulated vascular endothelia,
acquire these capacities after treatment with activating agents,
such as the chemotactic peptides C5a or fMLP [61. The increase
of plasma levels of C5a during hemodialysis, and its augmenta-
tive effect in the levels of CR3/Mac- 1 expression have been
found to correlate with the maximum decrease of neutrophil
counts [36]. Therefore, the triggering of neutrophil activation by
the chemoattractant factor C5a could be responsible of the
initiation of the cascade of events leading to transient leuko-
penic phenomena, and may contribute to the hypoxemia asso-
ciated with Cuprophane hemodialysis.
Our results showing the rapid overexpression on neutrophil
plasma membrane of CD! 1/CD 18 molecules support a mecha-
nism of translocation and mobilization from an internal pool,
probably due to activation of neutrophils during hemodialysis.
In this sense, we have previously reported the intracellular
localization of CD! ib, CD! ic and CDI8 molecules in tertiary
granules of neutrophils, which are readily mobilized and fused
with plasma membrane upon treatment with degranulatory
agents [31, 32, 37, 38].
The physiologic importance of the upregulated expression of
CD11b, CD11c and CD18 integrins in neutrophil adhesion to
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endothelia during hemodialysis still remains uncertain. Both the
Mac-i overexpression and its functional activity do not appear
to be necessarily associated in activated neutrophils [39, 401.
However, it is likely that these molecules play a pivotal role in
reinforcing initial adhesive interactions mediated by other mo-
lecular pathways as well as in regulating diapedesis, chemotaxis
and transendothelial migration. This is supported by results
showing the inhibitory effects exerted by anti-CD 18 antibodies
on the irreversible attachment of neutrophils to inflammed
venules in vivo, whereas they do not affect the initial interaction
of neutrophil with endothelial cells [411. Furthermore, anti-
CD18 antibodies have been also reported to block tissue accu-
mulation of neutrophils induced by local injection of chemoat-
tractants [42]. By contrast, the transient neutropenia and
pulmonary sequestration induced by sistemic injection of fMLP
was found to be CD11/CD18 independent [42]. Whether CDll/
CD18 dependent and/or independent adhesion mechanisms are
operating in Cuprophane mediated neutropenia remain un-
known and deserve further research.
We have observed a rapid decrease of Leu-8/LAM- 1 cell
surface expression in human neutrophils after activation with
different stimuli or from Cuprophane dialyzed patients. Simi-
larly, a rapid downregulation of mouse MEL-l4 and human
LAM-i antigens have been observed by in vitro neutrophil
activation [43—45]. The rapid downmodulation of Leu-8/
LAM-i, concomitant with the in vivo decline of human neutro-
phil counts, may indicate a role for this molecule in the early
stages of neutrophil-endothelial cell interaction and extravasa-
tion. After initial binding of neutrophils to endothelial glycopro-
teins, a rapid mechanism of downregulation operates by shedding
the Leu-8/LAM- 1 molecule [441 to ensure the extravasation
and/or detachment to continue. Interestingly, the Leu-8/LAM-i
protein contains an amino-terminal lectin-like domain which
could be responsible of interactions with carbohydrates on
counterpart ligands [17, 21].
We report for the first time the downregulation of the
neutrophil expression of CD43 by both in vivo hemodialysis
with the Cuprophane membrane and in vitro activation. This
Fig. 4. Time course of cell surface up- and downregulatory
effects on the expression of adhesion receptors on
neutrophils induced by dialysis with Cuprophane
membranes. Neutrophils isolated from blood samples of
patients at different times after the beginning of dialysis
C were stained by anti-CD11a TSIIII, anti-CD11b Bear 1,
anti-CD18 TS1/i8 (A), and anti-LAM-I Leu-8 and the anti-l00 / CD43 HP2/2l mAb (B), and subjected to flow cytometry/ analysis as described in Methods. Data are expressed as/ percents of increase or decrease of antigen expression,50 \ / calculated from means of specific fluorescence intensity
values of three separate and independent experiments. (C)
\// Variations in neutrophil counts in patients undergoing
__________________
hemodialysis. Neutrophils from dialysis with Cuprophane
15 30 60 (0) or polyacrylonitrile (0) membranes were counted asdescribed in Methods. Data are percents on neutrophils
Time, minutes calculated from means of five independent experiments.
event might account for a further enhancement of cell-cell
interactions during neutrophil activation. The CD43 molecule is
a major component of leukocyte glycocalix which bears a great
proportion of cell surface sialic acids [27, 46]. This is an
accordance with early studies describing a diminished negative
cell surface charge on neutrophils upon interaction with C5a or
C5a des Arg [47]. Very recently, a role for the CD43 molecule
in cell adhesion has been postulated by the capacity of antigen-
presenting cells to bind specifically to immobilized purified
CD43 [48].
Kinetic studies showing the recovery of normal levels of
expression of the CD! 1/CD 18 and Leu-8/LAM-l adhesion
molecules after one hour of hemodialysis may suggest the
existence of rapidly acting regulatory mechanisms. By contrast,
the expression of CD43 was not restored after one hour of
hemodialysis, suggesting a regulatory mechanism of antigen
expression different to those discussed above for the other
adhesion receptors. Preliminary studies point to a proteolytic
cleavage with specific cellular proteases as the mechanism
responsible for the decreased CD43 expression during neutro-
phil activation (M.R. Campanero et a!, unpublished results). In
this regard, the partial proteolytic cleavage of CD43 by exoge-
nous proteases has been recently described [49], which in
combination with neuraminidase resulted in the loss of the
epitopes recognized by anti-CD43 antibodies.
The differential regulation of these adhesion receptors during
the course of hemodialysis provides a molecular mechanism to
understand the rapid leukoaggregation and neutropenic effects
associated with the Cuprophane dialyzer. The precise role of
these adhesion molecules in neutropenic phenomena and the
dissection of discrete steps in this process associated with
hemodialysis deserve further research.
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